Sutezolid is an investigational antibiotic from the oxazolidinone class, currently being studied for the treatment of tuberculosis, especially multidrug-resistant and extensively drug-resistant forms. It works as a bacterial protein synthesis inhibitor and is structurally related to linezolid but with a sulfur atom replacing the morpholine oxygen. It is grouped under the following drug class(es): Oxazolidinones. The directory classifies it as a under development API with a synthetic source/manufacturing origin. Other names for this substance include Oxazolidininone and sutezolidum. Its PubChem CID is 465951.
Sutezolid
| CAS No | 168828-58-8 |
|---|---|
| Molecular Formula | C16H20FN3O3S |
| Molecular Weight | 353.4 g/mol |
| Synonyms | N-[[(5S)-3-(3-fluoro-4-thiomorpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Sutezolid is an investigational antibiotic from the oxazolidinone class, currently being studied for the treatment of tuberculosis, especially multidrug-resistant and extensively drug-resistant forms.
The listed CAS number is 168828-58-8.
The listed molecular formula is C16H20FN3O3S.
The listed molecular weight is 353.4 g/mol.
N-[[(5S)-3-(3-fluoro-4-thiomorpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide.
The source lists Oxazolidininone and sutezolidum.